CHAMOUN NASSIB 4
4 · ASPECT MEDICAL SYSTEMS INC · Filed Nov 9, 2009
Insider Transaction Report
Form 4
CHAMOUN NASSIB
DirectorPresident and CEO
Transactions
- Disposition to Issuer
Apect Medical Systems, Inc. Common Stock Option
2009-11-06−10,001→ 0 totalExercise: $10.00Exp: 2012-01-01→ Aspect Medical Systems, Inc. Common Stock (10,001 underlying) - Disposition to Issuer
Apect Medical Systems, Inc. Common Stock Option
2009-11-06−55,556→ 0 totalExercise: $11.82Exp: 2018-02-12→ Aspect Medical Systems, Inc. Common Stock (55,556 underlying) - Disposition to Issuer
Apect Medical Systems, Inc. Common Stock Option
2009-11-06−64,999→ 0 totalExercise: $10.00Exp: 2012-01-01→ Aspect Medical Systems, Inc. Common Stock (64,999 underlying) - Disposition to Issuer
Apect Medical Systems, Inc. Common Stock Option
2009-11-06−5,000→ 0 totalExercise: $3.85Exp: 2012-07-05→ Aspect Medical Systems, Inc. Common Stock (5,000 underlying) - Disposition to Issuer
Aspect Medical Systems, Inc. Common Stock
2009-11-06$12.00/sh−84,721$1,016,652→ 0 total - Disposition to Issuer
Apect Medical Systems, Inc. Common Stock Option
2009-11-06−6,555→ 0 totalExercise: $3.68Exp: 2013-01-24→ Aspect Medical Systems, Inc. Common Stock (6,555 underlying) - Disposition to Issuer
Apect Medical Systems, Inc. Common Stock Option
2009-11-06−25,000→ 0 totalExercise: $11.69Exp: 2011-02-21→ Aspect Medical Systems, Inc. Common Stock (25,000 underlying) - Disposition to Issuer
Apect Medical Systems, Inc. Common Stock Option
2009-11-06−7,982→ 0 totalExercise: $3.68Exp: 2013-01-24→ Aspect Medical Systems, Inc. Common Stock (7,982 underlying) - Disposition to Issuer
Apect Medical Systems, Inc. Common Stock Option
2009-11-06−73,889→ 0 totalExercise: $4.44Exp: 2019-02-10→ Aspect Medical Systems, Inc. Common Stock (73,889 underlying)
Footnotes (2)
- [F1]Reflects shares of restricted stock that were exchanged for a cash payment of $12.00 per share in connection with the merger (the "Merger") of Transformer Delaware Corp. with and into Aspect Medical Systems, Inc.
- [F2]This option was cancelled in the Merger for a cash payment per underlying share equal to the difference between the exercise price and $12.00.